KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iqvia Holdings (IQV) Cost of Revenue: 2012-2025

Historic Cost of Revenue for Iqvia Holdings (IQV) over the last 14 years, with Sep 2025 value amounting to $2.7 billion.

  • Iqvia Holdings' Cost of Revenue rose 8.30% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 billion, marking a year-over-year increase of 6.08%. This contributed to the annual value of $10.0 billion for FY2024, which is 2.92% up from last year.
  • As of Q3 2025, Iqvia Holdings' Cost of Revenue stood at $2.7 billion, which was up 1.22% from $2.7 billion recorded in Q2 2025.
  • Over the past 5 years, Iqvia Holdings' Cost of Revenue peaked at $2.7 billion during Q3 2025, and registered a low of $2.3 billion during Q3 2021.
  • Its 3-year average for Cost of Revenue is $2.5 billion, with a median of $2.5 billion in 2024.
  • Data for Iqvia Holdings' Cost of Revenue shows a peak YoY surged of 36.33% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Iqvia Holdings' Cost of Revenue stood at $2.4 billion in 2021, then increased by 1.82% to $2.4 billion in 2022, then climbed by 2.95% to $2.5 billion in 2023, then increased by 4.12% to $2.6 billion in 2024, then climbed by 8.30% to $2.7 billion in 2025.
  • Its Cost of Revenue stands at $2.7 billion for Q3 2025, versus $2.7 billion for Q2 2025 and $2.5 billion for Q1 2025.